NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 21,464 Value ($000) $56 Avg Close — Range —
Q1 2023
Shares 8,005 Value ($000) $33 Avg Close — Range —
Q4 2022
Shares 18,301 Value ($000) $92 Avg Close — Range —
Q3 2022
Shares 18,301 Value ($000) $239 Avg Close — Range —
Q2 2022
Shares 18,301 Value ($000) $235 Avg Close — Range —
Q1 2022
Shares 18,301 Value ($000) $279 Avg Close — Range —
Q4 2021
Shares 11,665 Value ($000) $207 Avg Close — Range —
Q3 2021
Shares 11,665 Value ($000) $245 Avg Close — Range —
Q2 2021
Shares 11,665 Value ($000) $230 Avg Close — Range —
Q1 2021
Shares 11,665 Value ($000) $339 Avg Close — Range —
Q4 2020
Shares 11,665 Value ($000) $353 Avg Close — Range —
Q3 2020
Shares 11,665 Value ($000) $186 Avg Close — Range —
Q2 2020
Shares 11,665 Value ($000) $230 Avg Close — Range —
Q1 2020
Shares 11,665 Value ($000) $144 Avg Close — Range —
Q4 2019
Shares 11,665 Value ($000) $216 Avg Close — Range —